$IMAX

Rosenblatt maintains Buy rating on Imax, $65 price target

Rosenblatt maintained a Buy rating and $65 price target on Imax, implying a 25.8% upside. The firm cited strong box office performance, with Q3 Gross Box Office at $712 million, up 94% YoY, driven by 'The Odyssey'. Analysts expect continued growth from upcoming film releases.

Original reporting
Published Oct 14, 2026, 11:56 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 14, 2026, 11:58 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Rosenblatt maintains Buy rating on Imax, $65 price target — source image
Decision brief

The 30-second read

$IMAXBullishMed
01

Why it matters

The new target suggests a sizable upside, likely prompting short‑term buying.

02

Market read

Analyst upgrade and higher target could move IMAX stock in the near term.

03

What to watch

Potential supply constraints at IMAX locations and macro‑economic headwinds could limit upside.

Relevance 6/10Novelty 5/10Timing: today

Background

Rosenblatt maintains a Buy rating on IMAX with a $65 price target after reporting record quarterly box office results.

Company-level read

Ticker impact

$IMAXBullishMedium confidence
Context

Rosenblatt upgraded its rating to Buy and set a new $65 price target, implying 25.8% upside from the recent close.

Expected impact

likely upward pressure as investors price in the new target

Evidence & confidence

The note provides fresh guidance and a concrete upside estimate, which can influence short‑term demand.

Market effects

May lift sentiment for the cinema and entertainment exhibition sector.

Primarily U.S. market impact; limited regional effect.

Modest global relevance, confined to IMAX and peers.

Counterpoint

The price target may be overly optimistic given competitive streaming pressures.

Key entities

  • Rosenblatt

    Equity research firm issuing the rating and target.

  • IMAX Corp

    Cinema technology and exhibition company.

Related articles

$IMAXHighAI 8/10

Wall Street Bets on Box Office Resurgence

Exhibitor stocks rose 70% this year, with MoffettNathanson predicting $10.5B in box-office receipts, down 8% from 2019. Analysts raised target prices for Imax to $64 and Cinemark to $41. Legendary made a new offer for Lionsgate, while Publicis Group's acquisition of LiveRamp was approved with conditions. 32 Equity and General Atlantic plan a sports investment fund.

$IMAXMed

IMAX box office surge drives Wedbush target hike

Wedbush raised its price target for IMAX Corp. to $60, citing record Q3 box office performance and strong financial projections. The firm expects $712M in global IMAX box office revenue, surpassing 2026 guidance. Wedbush forecasts Q3 revenue of $161M, EBITDA of $84M, and EPS of $0.98, all above consensus. Growth drivers include more IMAX titles, global expansion, and alternative content. IMAX is set to report Q3 results the week of October 26.

$IMAXHigh

Imax is a must for movie theaters, making the stock a buy, Morgan Stanley says

Morgan Stanley initiated coverage of Imax with an overweight rating and a $63 price target, suggesting 18% upside. The bank cites Imax's growing network, film slate, and box office revenue growth. Imax's box office is projected to reach $1.7 billion in 2028, up from $1.5 billion in 2026. The success of 'The Odyssey' highlights the value of Imax's technology and brand. 12 of 14 analysts rate Imax a buy or strong buy, and shares are up 21% over the past three months.

$AMCHighAI 8/10

AMC Spikes 7% as Refinancing Pushes Maturities From 2029 to 2031; Cinemark and IMAX Edge Higher

AMC Entertainment (AMC) shares rose 7% to $2.88 after announcing debt refinancing, pushing its nearest large maturity from 2029 to 2031. The move involves a private placement of first lien notes due 2031 and a cash tender offer for outstanding 2029 notes, funded by new debt facilities. Cinemark (CNK) and IMAX (IMAX) stocks also rose, but less significantly. AMC's refinancing aims to simplify its debt structure and extend maturities, though it does not reduce the total debt.

$IMAXMed

IMAX at Bank of America 2026 Media,Communications & Entertainment Conference: global surge

IMAX Corporation (IMAX) reported strong global growth at the Bank of America 2026 Media, Communications & Entertainment Conference. CEO Rich Gelfond highlighted record box office performance, international expansion, and new revenue streams. Current-quarter box office is on track to exceed $600 million, with significant contributions from international markets and local-language films. The company operates 1,800 theaters, with 500 in backlog, and aims to expand further. IMAX is also diversifying